CVE-2026-20595 MediaTek, Inc. CVE debrief

Who should care

Defenders and system administrators responsible for managing systems with neuropilot should assess exposure and apply the patch to prevent potential privilege escalation. This includes reviewing system configurations to ensure proper management of the System privilege and monitoring for suspicious activity related to local privilege escalation. Additionally, security teams and vulnerability management teams should be aware of this vulnerability and its to

Why it matters

CVE-2026-20595 is a potential out-of-bounds write vulnerability in neuropilot that could lead to local escalation of privilege. Defenders should prioritize verifying and applying the patch (ALPS11263078) and review system configurations to ensure proper management of the System privilege.

• Verification of patch application is required to prevent potential exploitation
• System administrators should review configurations to ensure proper management of the System privilege
• Monitoring for suspicious activity related to local privilege escalation is recommended

Technical summary

A possible out-of-bounds write vulnerability in neuropilot could lead to local escalation of privilege if a malicious actor has already obtained the System privilege. User interaction is not needed for exploitation. A patch (ALPS11263078) is available to address this issue. This vulnerability is caused by a missing bounds check in neuropilot, which could allow an attacker to write data outside the intended buffer, potentially leading to privilege escalation. The vulnerability affects certain products that use neuropilot. Defenders should prioritize verifying and applying the patch to prevent potential exploitation.

Defensive priority

Defenders should prioritize verifying and applying the patch (ALPS11263078) to prevent potential privilege escalation.

Recommended defensive actions

• Verify and apply the patch (ALPS11263078) to neuropilot
• Review system configurations to ensure the System privilege is properly managed
• Monitor for any suspicious activity related to local privilege escalation
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
• Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance
• Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed
• Check relevant monitoring, detection, and logs for exposed assets that need extra review

Evidence notes

The CVE record and Mediatek's security bulletin provide initial details about the vulnerability. However, additional information about affected products and versions is required for comprehensive risk assessment.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.